![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NOVARTIS COMPLETES ACQUISITION OF 98 PERCENT OF EON LABS
NOVARTIS COMPLETES ACQUISITION OF 98 PERCENT OF EON LABS
July 21, 2005
Novartis announced today that it has completed the acquisition of approximately 98 percent of U.S.-based generic pharmaceutical company Eon Labs, Inc. Following the acquisition last month of Hexal AG of Germany, the Sandoz generics division of Novartis now has a strong foothold and a leading position in the highly competitive generic drug industry.
PrimeZone (http://www.primezone.com/newsroom/news.html?d=82490)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct